title: Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.
abstract: Angiotensin II (Ang II) plays a major role in the pathogenesis of insulin resistance and diabetes by inhibiting insulin's metabolic and potentiating its trophic effects. Whereas the precise mechanisms involved remain ill-defined, they appear to be associated with and dependent upon increased oxidative stress. We found Ang II to block insulin-dependent GLUT4 translocation in L6 myotubes in an NO- and O(2)(*-)-dependent fashion suggesting the involvement of peroxynitrite. This hypothesis was confirmed by the ability of Ang II to induce tyrosine nitration of the MAP kinases ERK1/2 and of protein kinase B/Akt (Akt). Tyrosine nitration of ERK1/2 was required for their phosphorylation on Thr and Tyr and their subsequent activation, whereas it completely inhibited Akt phosphorylation on Ser(473) and Thr(308) as well as its activity. The inhibitory effect of nitration on Akt activity was confirmed by the ability of SIN-1 to completely block GSK3alpha phosphorylation in vitro. Inhibition of nitric oxide synthase and NAD(P)Hoxidase and scavenging of free radicals with myricetin restored insulin-stimulated Akt phosphorylation and GLUT4 translocation in the presence of Ang II. Similar restoration was obtained by inhibiting the ERK activating kinase MEK, indicating that these kinases regulate Akt activation. We found a conserved nitration site of ERK1/2 to be located in their kinase domain on Tyr(156/139), close to their active site Asp(166/149), in agreement with a permissive function of nitration for their activation. Taken together, our data show that Ang II inhibits insulin-mediated GLUT4 translocation in this skeletal muscle model through at least two pathways: first through the transient activation of ERK1/2 which inhibit IRS-1/2 and second through a direct inhibitory nitration of Akt. These observations indicate that not only oxidative but also nitrative stress play a key role in the pathogenesis of insulin resistance. They underline the role of protein nitration as a major mechanism in the regulation of Ang II and insulin signaling pathways and more particularly as a key regulator of protein kinase activity.
authors.affiliation: Laboratoire de Bioénergétique Fondamentale et Appliquée, INSERM U884, Grenoble Universités, Grenoble, France.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Csibi
authors.forename: David
authors.initials: D
authors.lastname: Communi
authors.forename: Nathalie
authors.initials: N
authors.lastname: Müller
authors.forename: Serge P
authors.initials: SP
authors.lastname: Bottari
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D002478:Cells, Cultured; D051275:Glucose Transporter Type 4 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D055504:Insulin Receptor Substrate Proteins / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism*; D018485:Muscle Fibers, Skeletal / Q000378:metabolism; D018482:Muscle, Skeletal / Q000166:cytology; D009566:Nitrates / Q000378:metabolism*; D021381:Protein Transport; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D051381:Rats; D014443:Tyrosine / Q000378:metabolism*
chemical_list: D051275:Glucose Transporter Type 4; D007328:Insulin; D055504:Insulin Receptor Substrate Proteins; C526296:Irs1 protein, rat; C526299:Irs2 protein, rat; D009566:Nitrates; D000804:Angiotensin II; D014443:Tyrosine; D051057:Proto-Oncogene Proteins c-akt; D048052:Mitogen-Activated Protein Kinase 3
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Sep;293(3):R974-80
references.pmid: 17581838
references.citation: Free Radic Biol Med. 2009 Aug 15;47(4):458-67
references.pmid: 19477267
references.citation: Am J Physiol. 1996 Nov;271(5 Pt 1):C1424-37
references.pmid: 8944624
references.citation: Am J Physiol Renal Physiol. 2003 Aug;285(2):F178-90
references.pmid: 12842859
references.citation: Diabetes. 2005 Apr;54(4):959-67
references.pmid: 15793233
references.citation: Metabolism. 2005 Dec;54(12):1659-68
references.pmid: 16311101
references.citation: Curr Opin Pharmacol. 2006 Apr;6(2):136-41
references.pmid: 16483848
references.citation: N Engl J Med. 2008 Apr 10;358(15):1547-59
references.pmid: 18378520
references.citation: Diabetologia. 2004 Sep;47(9):1535-40
references.pmid: 15316606
references.citation: Am J Physiol. 1998 Jan;274(1):C214-20
references.pmid: 9458730
references.citation: N Engl J Med. 2002 Jun 20;346(25):1999-2001
references.pmid: 12075063
references.citation: Nat Rev Drug Discov. 2007 Aug;6(8):662-80
references.pmid: 17667957
references.citation: J Inorg Biochem. 2006 Dec;100(12):2079-86
references.pmid: 17095095
references.citation: Am J Hypertens. 2005 Jan;18(1):121-8
references.pmid: 15691626
references.citation: J Biol Chem. 2000 Mar 31;275(13):9324-31
references.pmid: 10734074
references.citation: Free Radic Biol Med. 2009 Oct 1;47(7):975-82
references.pmid: 19591921
references.citation: Am J Physiol. 1999 Nov;277(5):E920-6
references.pmid: 10567021
references.citation: Am J Physiol Heart Circ Physiol. 2003 Oct;285(4):H1396-403
references.pmid: 12791589
references.citation: Diabetologia. 2005 Aug;48(8):1590-603
references.pmid: 15988580
references.citation: Diabetes. 1997 Nov;46(11):1691-700
references.pmid: 9356014
references.citation: J Biol Chem. 2003 Sep 5;278(36):33972-7
references.pmid: 12821649
references.citation: J Chem Biol. 2009 Mar;2(1):11-25
references.pmid: 19568789
references.citation: FEBS Lett. 2005 Sep 12;579(22):5100-4
references.pmid: 16139272
references.citation: Hypertension. 2001 Oct;38(4):884-90
references.pmid: 11641303
references.citation: Expert Opin Ther Targets. 2008 Oct;12(10):1257-63
references.pmid: 18781824
references.citation: Pharmacol Rev. 2002 Dec;54(4):619-34
references.pmid: 12429871
references.citation: Diabet Med. 2006 Jun;23(6):666-74
references.pmid: 16759310
references.citation: Diabetes Care. 2002 Aug;25(8):1439-43
references.pmid: 12145247
references.citation: Diabetes. 2006 Mar;55(3):751-9
references.pmid: 16505239
references.citation: Hypertension. 1995 Dec;26(6 Pt 2):1074-8
references.pmid: 7498971
references.citation: J Biol Chem. 2006 Nov 17;281(46):35137-46
references.pmid: 16982630
references.citation: J Cell Sci. 2009 Jun 15;122(Pt 12):2043-54
references.pmid: 19470583
references.citation: Free Radic Biol Med. 2008 Sep 1;45(5):619-26
references.pmid: 18539157
references.citation: Endocrinology. 2000 Sep;141(9):3120-6
references.pmid: 10965882
references.citation: Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):147-52
references.pmid: 18316950
references.citation: Diabetologia. 2001 Jul;44(7):834-8
references.pmid: 11508267
references.citation: Acta Diabetol. 2005 Apr;42 Suppl 1:S42-9
references.pmid: 15868119
references.citation: J Cell Mol Med. 2011 Feb;15(2):258-69
references.pmid: 20015194
references.citation: Eur J Pharmacol. 2005 Sep 27;520(1-3):179-87
references.pmid: 16139267
references.citation: Toxicology. 2005 Mar 15;208(2):299-303
references.pmid: 15691593
references.citation: Exp Cell Res. 2005 Aug 15;308(2):291-9
references.pmid: 15921682
references.citation: Cardiovasc Diabetol. 2007 Apr 03;6:12
references.pmid: 17407587
references.citation: J Biol Chem. 2007 Nov 2;282(44):32453-61
references.pmid: 17804409
references.citation: J Physiol. 2008 Aug 15;586(16):4011-6
references.pmid: 18591189
references.citation: Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E345-51
references.pmid: 18073321
references.citation: Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1597-602
references.pmid: 15072967
references.citation: Nat Med. 2001 Oct;7(10):1138-43
references.pmid: 11590438
references.citation: J Biol Chem. 2002 Oct 11;277(41):38021-8
references.pmid: 12149249
references.citation: Mol Cell. 2004 Sep 10;15(5):661-75
references.pmid: 15350212
references.citation: J Biol Chem. 2004 Jun 25;279(26):27257-62
references.pmid: 15084586
references.citation: Hypertension. 2004 May;43(5):1003-10
references.pmid: 15037562
references.citation: Hypertension. 2003 May;41(5):1096-101
references.pmid: 12707286
references.citation: J Hypertens. 2006 Jul;24(7):1405-12
references.pmid: 16794491
references.citation: Biochem Pharmacol. 2005 Sep 15;70(6):811-23
references.pmid: 15899473
references.citation: Biochem J. 2000 Nov 15;352 Pt 1:219-25
references.pmid: 11062076
references.citation: Diabetes Metab. 2004 Dec;30(6):498-505
references.pmid: 15671919
references.citation: Sci Signal. 2008 Jun 17;1(24):pe29
references.pmid: 18560018
references.citation: J Clin Endocrinol Metab. 2003 Apr;88(4):1753-9
references.pmid: 12679469
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11584-9
references.pmid: 9751709
references.citation: Ann Pharmacother. 2004 Oct;38(10):1731-8
references.pmid: 15353571
references.citation: J Mol Endocrinol. 2007 Nov;39(5):351-63
references.pmid: 17975262
references.citation: J Hypertens. 2008 Oct;26(10):1891-900
references.pmid: 18806611
references.citation: J Biol Chem. 2004 Mar 19;279(12):10962-72
references.pmid: 14701865
references.citation: FASEB J. 2000 Feb;14(2):271-8
references.pmid: 10657983
references.citation: Diabetes. 2001 May;50(5):1093-101
references.pmid: 11334413
references.citation: Nephrol Dial Transplant. 2004 Dec;19(12):3012-20
references.pmid: 15574998
references.citation: Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E353-9
references.pmid: 15494608
references.citation: J Biol Chem. 2005 Mar 4;280(9):7511-8
references.pmid: 15632167
references.citation: Endocrinol Metab Clin North Am. 2005 Mar;34(1):63-75
references.pmid: 15752922